{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:35:54Z","timestamp":1793039754502,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM113134"],"award-info":[{"award-number":["P20GM113134"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL098423"],"award-info":[{"award-number":["R01HL098423"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.lfs.2019.116665","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T19:31:13Z","timestamp":1563305473000},"page":"116665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The effects of Tel2 on cardiomyocyte survival"],"prefix":"10.1016","volume":"232","author":[{"given":"Naaiko","family":"Yorichika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana K.","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Thakore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Higa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2019.116665_bb0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mTOR signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.lfs.2019.116665_bb0010","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-017-0865-4","article-title":"The mTOR signaling pathway in myocardial dysfunction in type 2 diabetes mellitus","volume":"17","author":"Suhara","year":"2017","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.lfs.2019.116665_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","article-title":"mTOR as a central hub of nutrient signalling and cell growth","volume":"21","author":"Kim","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.lfs.2019.116665_bb0020","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.116665_bb0025","series-title":"Molecules to Medicine with mTOR: Translating Critical Pathways into Novel Therapeutic Strategies","first-page":"263","article-title":"Role of mammalian target of rapamycin (mTOR) in cardiac homeostasis in metabolic disorders","author":"Liu","year":"2016"},{"issue":"1","key":"10.1016\/j.lfs.2019.116665_bb0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.lfs.2019.116665_bb0035","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4161\/auto.24398","article-title":"MTOR overactivation and interrupted autophagy flux in obese hearts: a dicey assembly?","volume":"9","author":"Zhang","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2019.116665_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.yjmcc.2016.04.011","article-title":"mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53\/JNK-mediated apoptosis","volume":"97","author":"Mazelin","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.lfs.2019.116665_bb0045","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI43008","article-title":"MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice","volume":"120","author":"Zhang","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.lfs.2019.116665_bb0050","doi-asserted-by":"crossref","first-page":"H75","DOI":"10.1152\/ajpheart.00241.2012","article-title":"Cardiac mTOR protects the heart against ischemia-reperfusion injury","volume":"303","author":"Aoyagi","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"12","key":"10.1016\/j.lfs.2019.116665_bb0055","doi-asserted-by":"crossref","first-page":"H1530","DOI":"10.1152\/ajpheart.00008.2015","article-title":"Cardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion","volume":"308","author":"Aoyagi","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2019.116665_bb0060","doi-asserted-by":"crossref","first-page":"H1256","DOI":"10.1152\/ajpcell.00338.2010","article-title":"mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy","volume":"299","author":"Song","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"10.1016\/j.lfs.2019.116665_bb0065","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2007.10.052","article-title":"Tel 2 regulates the stability of PI3K-related protein kinases","volume":"131","author":"Takai","year":"2007","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.lfs.2019.116665_bb0070","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1101\/gad.1934210","article-title":"A genetic screen identifies the triple T complex required for DNA damage signaling and ATM and ATR stability","volume":"24","author":"Hurov","year":"2010","journal-title":"Genes Dev."},{"issue":"26","key":"10.1016\/j.lfs.2019.116665_bb0075","doi-asserted-by":"crossref","first-page":"20109","DOI":"10.1074\/jbc.M110.121699","article-title":"Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly","volume":"285","author":"Kaizuka","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.lfs.2019.116665_bb0080","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/01.CIR.100.23.2373","article-title":"Adenoviral gene transfer of activated phosphatidylinositol 3\u2032-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro","volume":"100","author":"Matsui","year":"1999","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.lfs.2019.116665_bb0085","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1172\/JCI23073","article-title":"PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia\/reperfusion injury","volume":"115","author":"Nagoshi","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.lfs.2019.116665_bb0090","doi-asserted-by":"crossref","first-page":"H659","DOI":"10.1152\/ajpheart.00452.2017","article-title":"Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes","volume":"314","author":"Baba","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2019.116665_bb0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pharmthera.2011.11.004","article-title":"The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion","volume":"133","author":"Raedschelders","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.lfs.2019.116665_bb0100","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1","volume":"284","author":"Thoreen","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2019.116665_bb0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ncb2651","article-title":"SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2\/Tti1 degradation and promote survival in multiple myeloma","volume":"15","author":"Fernandez-Saiz","year":"2013","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.lfs.2019.116665_bb0110","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00294-018-0817-9","article-title":"Branching the Tel2 pathway for exact fit on phosphatidylinositol 3-kinase-related kinases","volume":"64","author":"Sugimoto","year":"2018","journal-title":"Curr. Genet."},{"issue":"6","key":"10.1016\/j.lfs.2019.116665_bb0115","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.101.6.660","article-title":"Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart","volume":"101","author":"Fujio","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2019.116665_bb0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.lfs.2019.116665_bb0125","doi-asserted-by":"crossref","first-page":"14071","DOI":"10.1074\/jbc.R109.094003","article-title":"Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony","volume":"285","author":"Foster","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2019.116665_bb0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yjmcc.2014.08.015","article-title":"Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury","volume":"78","author":"Morciano","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.lfs.2019.116665_bb0135","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lfs.2019.116665_bb0140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and transferrin regulate Ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"issue":"7253","key":"10.1016\/j.lfs.2019.116665_bb0145","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.lfs.2019.116665_bb0150","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1128\/MCB.24.15.6710-6718.2004","article-title":"mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells","volume":"24","author":"Murakami","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2019.116665_bb0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1101\/gad.271445.115","article-title":"A gain-of-function senescence bypass screen identifies the homeobox transcription factor DLX2 as a regulator of ATM-p53 signaling","volume":"30","author":"Wang","year":"2016","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.lfs.2019.116665_bb0160","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s10616-016-0001-3","article-title":"Real-time monitoring of hypertrophy in HL-1 cardiomyocytes by impedance measurements reveals different modes of growth","volume":"68","author":"Bloch","year":"2016","journal-title":"Cytotechnology"},{"issue":"1","key":"10.1016\/j.lfs.2019.116665_bb0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/MCB.24.1.200-216.2004","article-title":"mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E","volume":"24","author":"Fingar","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2019.116665_bb0170","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","article-title":"AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity","volume":"70","author":"Chresta","year":"2010","journal-title":"Cancer Res."},{"issue":"7432","key":"10.1016\/j.lfs.2019.116665_bb0175","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature11682","article-title":"Mammalian heart renewal by pre-existing cardiomyocytes","volume":"493","author":"Senyo","year":"2013","journal-title":"Nature"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519305910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519305910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:45:46Z","timestamp":1793036746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519305910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":35,"alternative-id":["S0024320519305910"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116665","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of Tel2 on cardiomyocyte survival","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116665"}}